KRISTIN WILLIAMS: Open Payments
NPI 1508620824 · PUYALLUP, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$900 in 38 payments from 15 companies in 2025. Trend: 2023 $29 · 2024 $512 · 2025 $900
Food & beverage: $900
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $281 |
| Phathom Pharmaceuticals, Inc. | 3 | $110 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $93 |
| Corcept Therapeutics | 3 | $74 |
| GlaxoSmithKline, LLC. | 3 | $67 |
| PFIZER INC. | 3 | $61 |
| Lilly USA, LLC | 2 | $57 |
| ABBVIE INC. | 2 | $36 |
| Medtronic, Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: Ozempic, VOQUEZNA, CAPLYTA, Korlym, JARDIANCE, Rybelsus, SHINGRIX, PREVNAR 20.
Industry payments across WA — which companies pay providers there.
